Inhibition of neutrophil degranulation and superoxide production by sulfasalazine

This publication has 17 references indexed in Scilit:

• Arachidonic acid metabolites and their role in inflammatory bowel disease
  Gastroenterology, 1985
• Sulphasalazine in Rheumatoid Arthritis: An Old Drug Revived
  Journal of the Royal Society of Medicine, 1984
• Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.
  Journal of Clinical Investigation, 1982
• Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease
  New England Journal of Medicine, 1980
• Sulphasalazine in rheumatoid arthritis.
  BMJ, 1980
• The Effect of Sulfasalazine and Its Active Components on Human Polymorphonuclear Leukocyte Function in Relation to Ulcerative Colitis
  Acta Medica Scandinavica, 1979
• Inhibition of prostaglandin biosynthesis by sulphasalazine and its metabolites
  Prostaglandins, 1976
• A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin)
  Gut, 1973
• Absorption, metabolism, and excretion of salicylazosulfapyridine in man
  Clinical Pharmacology & Therapeutics, 1972
• Salazopyrin, a new sulfanilamide preparation. A. Therapeutic Results in Rheumatic Polyarthritis. B. Therapeutic Results in Ulcerative Colitis. C. Toxic Manifestations in Treatment with Sulfanilamide Preparations.
  Acta Medica Scandinavica, 1942